MC
ABBV icon

Montag & Caldwell’s AbbVie ABBV Stock Holding History

Montag & Caldwell’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$598K Hold
3,221
– – 0.13% 68
2025
Q1 		$675K Hold
3,221
– – 0.16% 60
2024
Q4 		$572K Sell
3,221
-414
-11% -$76.1K 0.12% 65
2024
Q3 		$718K Hold
3,635
– – 0.15% 59
2024
Q2 		$623K Sell
3,635
-87
-2% -$14.4K 0.13% 63
2024
Q1 		$678K Sell
3,722
-63
-2% -$10.9K 0.12% 58
2023
Q4 		$587K Hold
3,785
– – 0.1% 57
2023
Q3 		$564K Hold
3,785
– – 0.07% 62
2023
Q2 		$510K Sell
3,785
-5
-0.1% -$733 0.06% 62
2023
Q1 		$604K Sell
3,790
-91
-2% -$13.9K 0.08% 54
2022
Q4 		$627K Buy
3,881
+255
+7% +$39.1K 0.09% 53
2022
Q3 		$486K Buy
3,626
+405
+13% +$58.1K 0.07% 61
2022
Q2 		$493K Buy
+3,221
New +$492K 0.07% 64
2016
Q4 		– Sell
-15,100
Closed -$952K – 87
2016
Q3 		$952K Sell
15,100
-9,379
-38% -$607K 0.02% 47
2016
Q2 		$1.52M Sell
24,479
-1,950
-7% -$119K 0.03% 39
2016
Q1 		$1.51M Sell
26,429
-17,876
-40% -$996K 0.03% 39
2015
Q4 		$2.63M Sell
44,305
-11,625
-21% -$670K 0.05% 37
2015
Q3 		$3.04M Sell
55,930
-11,970
-18% -$779K 0.05% 38
2015
Q2 		$4.56M Sell
67,900
-3,800
-5% -$248K 0.06% 39
2015
Q1 		$4.2M Buy
71,700
+26,100
+57% +$1.58M 0.05% 40
2014
Q4 		$2.98M Buy
+45,600
New +$2.87M 0.03% 39
2013
Q4 		– Sell
-258,180
Closed -$11.5M – 97
2013
Q3 		$11.5M Sell
258,180
-70,600
-21% -$3.13M 0.09% 40
2013
Q2 		$13.6M Buy
+328,780
New +$14.4M 0.1% 38

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Montag & Caldwell's ABBV Position: Q2 2025 in Review

Montag & Caldwell held its AbbVie (ABBV) position steady in Q2 2025 at 3,221 shares worth $598K. The position accounts for 0.13% of the portfolio, ranked #68.

Montag & Caldwell first reported a position in ABBV in Q2 2013 and has held it in 23 quarters since. The position peaked at $13.6M in Q2 2013. 3,781 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • Montag & Caldwell held 3,221 shares of AbbVie worth $598K as of Q2 2025.
  • Montag & Caldwell left its AbbVie share count unchanged in Q2 2025.
  • AbbVie made up 0.13% of Montag & Caldwell's portfolio in Q2 2025, its #68 holding.
  • Montag & Caldwell first reported a position in AbbVie in Q2 2013 and has held it in 23 quarters since.
  • Montag & Caldwell's AbbVie position peaked at $13.6M in Q2 2013.
  • 3,781 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Montag & Caldwell's 13F filing for Q2 2025, filed 15 Aug 2025.